Clinical Trial

Safety, Tolerability, and Pharmacokinetic Profile of Grammidin, a Metered Dose Topical Spray in Healthy Volunteers

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the safety, tolerability, and pharmacokinetic profile of the Grammidin, a metered dose topical spray, compared to Grammidin lozenges following single administration in healthy volunteers .
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-27.
Trial Details
NCT Number NCT06859281
Lead Sponsor Valenta Pharm JSC
Conditions Pharyngitis
Enrollment 24 participants
Start Date 2024-12-10
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-10